1993 …2019

Research output per year

If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Elisabetta Munzone is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 59 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output

Long-term responders to trastuzumab monotherapy in first-line HER-2+ advanced breast cancer: Characteristics and survival data

Schmid, S., Klingbiel, D., Aebi, S., Goldhirsch, A., Mamot, C., Munzone, E., Nolè, F., Oehlschlegel, C., Pagani, O., Pestalozzi, B., Rochlitz, C., Thürlimann, B., Von Moos, R., Weder, P., Zaman, K. & Ruhstaller, T., Sep 10 2019, In : BMC Cancer. 19, 1, 902.

Research output: Contribution to journalArticle

Open Access
  • Neoadjuvant degarelix versus triptorelin in premenopausal patients who receive letrozole for locally advanced endocrine-responsive breast cancer: A randomized phase II trial

    International Breast Cancer Study Group, Feb 10 2019, In : Journal of Clinical Oncology. 37, 5, p. 386-395 10 p.

    Research output: Contribution to journalArticle

  • Pan-European Expert Meeting on the Use of Metronomic Chemotherapy in Advanced Breast Cancer Patients: The PENELOPE Project

    Cazzaniga, M. E., Munzone, E., Bocci, G., Afonso, N., Gomez, P., Langkjer, S., Petru, E., Pivot, X., Sánchez Rovira, P., Wysocki, P. & Torri, V., Feb 1 2019, In : Advances in Therapy. 36, 2, p. 381-406 26 p.

    Research output: Contribution to journalArticle